Bristol John W & Co Inc /Ny/ / TMO
Bristol John W & Co Inc /Ny/’s Thermo Fisher Scientific Inc Position
Does Bristol John W & Co Inc /Ny/ own Thermo Fisher Scientific Inc (TMO)? Yes — 342.8K shares worth $168M (+2.77% of its 13F portfolio) as of Q1 2026, down from 347.0K shares the prior filed quarter.
Position Value
$168M
Q1 2026
Shares
342.8K
% of Portfolio
+2.77%
Quarters Held
30
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 342.8K | $168M | +2.77% |
| Q4 2025 | 347.0K | $201M | +3.09% |
| Q3 2025 | 353.9K | $172M | +2.71% |
| Q2 2025 | 360.4K | $146M | +2.37% |
| Q1 2025 | 282.6K | $141M | +2.40% |
| Q4 2024 | 288.6K | $150M | +2.47% |
| Q3 2024 | 295.1K | $183M | +2.91% |
| Q2 2024 | 298.8K | $165M | +2.68% |
| Q1 2024 | 305.6K | $178M | +3.02% |
| Q4 2023 | 306.0K | $162M | +2.99% |
| Q3 2023 | 321.3K | $163M | +3.21% |
| Q2 2023 | 324.1K | $169M | +3.20% |
| Q1 2023 | 304.6K | $176M | +3.61% |
| Q4 2022 | 304.2K | $167M | +3.98% |
| Q3 2022 | 303.6K | $154M | +3.85% |
| Q2 2022 | 303.1K | $165M | +4.03% |
| Q1 2022 | 311.4K | $184M | +3.65% |
| Q4 2021 | 317.4K | $212M | +3.66% |
| Q3 2021 | 320.8K | $183M | +3.42% |
| Q2 2021 | 325.6K | $164M | +3.02% |
| Q1 2021 | 328.4K | $150M | +3.06% |
| Q4 2020 | 329.2K | $153M | +3.16% |
| Q3 2020 | 383.3K | $169M | +3.84% |
| Q2 2020 | 382.9K | $139M | +3.44% |
| Q1 2020 | 389.7K | $111M | +3.44% |
| Q4 2019 | 324.4K | $105M | +2.54% |
| Q3 2019 | 325.9K | $96M | +2.47% |
| Q2 2019 | 320.1K | $94M | +2.48% |
| Q1 2019 | 323.3K | $89M | +2.43% |
| Q4 2018 | 326.6K | $73M | +2.34% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bristol John W & Co Inc /Ny/’s full portfolio or all institutional holders of TMO.